STATKING Clinical Services Named to Annual Aggie 100 for the Second Consecutive Year
STATKING Clinical Services Named to Annual Aggie 100 for the Second Consecutive Year
COLLEGE STATION, Texas--(BUSINESS WIRE)--STATKING Clinical Services, Cincinnati, OH is among the top 100 companies from around the world selected for the 16th annual Aggie 100 which honors the fastest-growing companies owned or operated by former students of Texas A&M University. The Aggie 100 is founded and hosted by the McFerrin Center for Entrepreneurship at Texas A&M University.
The company was founded in 1989 by Dennis W. King, PhD, PStat, TAMU ’88 and has conducted over 500 clinical trials for the regulatory approval of drug and medical device products. Dr. King commented “Our staff here at STATKING continues to excel and their hard work has resulted in our company being named to the Aggie 100 for the second consecutive year.”
The 100 Aggie-owned companies with the highest compound annual revenue growth from 2017 to 2019 were revealed and recognized during a live-stream awards showcase on Friday, November 6, 2020. The awards production is available for viewing at tx.ag/2020Aggie100.
“The Aggie 100 brand represents the most elite group of successful Aggie entrepreneurs, whose endeavors have truly made our world a better place to live. Texas A&M recognizes both their individual efforts and their collective success, in the same way these Honorees acknowledge the important role our beloved university played in the development of their character. The McFerrin Center for Entrepreneurship proudly embodies the legacy through which our Aggie 100 Honorees can contribute to developing the next great generation of Aggie entrepreneurs.” said Blake Petty, Director of the McFerrin Center for Entrepreneurship.
A complete Aggie 100 list can be viewed at https://aggie100.com.
About STATKING Clinical Services
STATKING Clinical Services provides clinical trial services (clinical trial management, protocol development, biostatistics, clinical data management, clinical study monitoring, medical writing, medical monitoring, safety reporting, and project management) for clinical trials for the regulatory approval of novel drug and medical device products. The company is headquartered in Fairfield, OH. The company has provided support on 29 NDAs and BLAs, 13 PMAs, 3 NADAs and 24 510Ks over the past 31 years of service to the pharmaceutical, medical device and animal health industries. For more information, visit www.statkingclinical.com.
Contacts
STATKING Clinical Services
Rod Lashley, Executive Vice President 513-858-2989 x303
rod@statkingclinical.com